Cargando…

A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignancies

BACKGROUND: Epidermal growth factor receptor (EGFR) is a well-known target for cancer treatment. However, the authorized anti-EGFR monoclonal antibodies generally cause several toxic effects, especially severe cutaneous toxicities as well as infusion reactions, and the clinical indications are limit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Da, Pan, Hong, Wang, Wei, Xue, Yanan, Fang, Yong, Lou, Haizhou, Pan, Qin, Jin, Wei, Zheng, Yu, Han, Weidong, Zhu, Kongli, Zhao, Xianfeng, Xu, Rong, Han, Jin, Pan, Hongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071157/ https://www.ncbi.nlm.nih.gov/pubmed/37025261 http://dx.doi.org/10.1177/17588359231165968

Ejemplares similares

Immunochemotherapy achieved a complete response for metastatic adenocarcinoma of unknown primary based on gene expression profiling: a case report and review of the literature
por: Sheng, Jin, et al.
Publicado: (2023)

Thoracic SMARCA4-Deficient Undifferentiated Tumor With ALK Fusion Treated With Alectinib Achieved Remarkable Tumor Regression: Case Report
por: Sheng, Jin, et al.
Publicado: (2023)

Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo
por: Pan, Qin, et al.
Publicado: (2013)

ChIA-PIPE: A fully automated pipeline for comprehensive ChIA-PET data analysis and visualization
por: Lee, Byoungkoo, et al.
Publicado: (2020)

Inhibition of G9a promoted 5-fluorouracil (5-FU) induced gastric cancer cell apoptosis via ROS/JNK signaling pathway in vitro and in vivo
por: Lou, Haizhou, et al.
Publicado: (2019)

Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
por: Lu, Qian, et al.
Publicado: (2021)

Thermal Radiofrequency Ablation as an Adjuvant Therapy for Patients With Colorectal Liver Metastasis
por: Fan, Yaohua, et al.
Publicado: (2016)

Use of Metformin Alone Is Not Associated with Survival Outcomes of Colorectal Cancer Cell but AMPK Activator AICAR Sensitizes Anticancer Effect of 5-Fluorouracil through AMPK Activation
por: Sui, Xinbing, et al.
Publicado: (2014)

Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors
por: Saba, Nabil F., et al.
Publicado: (2012)

p53-induced autophagy and senescence
por: Sui, Xinbing, et al.
Publicado: (2015)

NF1 germline mutation in a Chinese family with colon cancer
por: Lou, Haizhou, et al.
Publicado: (2020)

A recurrent idiotype on monoclonal anti-human Ia antibodies
Publicado: (1982)

The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
por: Yuan, Meiqin, et al.
Publicado: (2022)

Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8(+) T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer
por: Shuai, Chong, et al.
Publicado: (2020)

miR-26a attenuates colitis and colitis-associated cancer by targeting the multiple intestinal inflammatory pathways
por: Zhang, Wei, et al.
Publicado: (2021)

Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells
por: Han, Weidong, et al.
Publicado: (2011)

TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization
por: Han, Yicheng, et al.
Publicado: (2022)

Preparation and characterization of a fully human monoclonal antibody specific for human tumor necrosis factor alpha
por: Liao, Xinmei, et al.
Publicado: (2021)

Suvemcitug as second-line treatment of advanced or metastatic solid tumors and with FOLFIRI for pretreated metastatic colorectal cancer: phase Ia/Ib open label, dose-escalation trials
por: Mao, C., et al.
Publicado: (2023)

Induction of Ia antigen in rat epidermal cells and gut epithelium by immunological stimuli
Publicado: (1982)

The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study
por: LoRusso, Patricia, et al.
Publicado: (2023)

Clinical characteristics and programmed cell death ligand-1 expression in adenocarcinoma in situ and minimally invasive adenocarcinoma of lung
por: Yu, Renke, et al.
Publicado: (2017)

Intestinal epithelial cell autophagy deficiency suppresses inflammation-associated colon tumorigenesis
por: Liu, Hao, et al.
Publicado: (2022)

Nec-1 Enhances Shikonin-Induced Apoptosis in Leukemia Cells by Inhibition of RIP-1 and ERK1/2
por: Han, Weidong, et al.
Publicado: (2012)

Autophagy: A novel therapeutic target for hepatocarcinoma (Review)
por: WANG, ZHANGGUI, et al.
Publicado: (2014)

SOCE and cancer: Recent progress and new perspectives
por: Xie, Jiansheng, et al.
Publicado: (2015)

Roles of PFKFB3 in cancer
por: Shi, Linlin, et al.
Publicado: (2017)

Development of Store-Operated Calcium Entry-Targeted Compounds in Cancer
por: Liang, Xiaojing, et al.
Publicado: (2021)

The benefit of anti-angiogenic therapy in EGFR exon 21 L858R mutant non-small cell lung cancer patients: a retrospective study
por: You, Liangkun, et al.
Publicado: (2022)

The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer
por: Zhai, Chongya, et al.
Publicado: (2021)

Depletion of epidermal langerhans cells and Ia immunogenicity from tape- stripped mouse skin
Publicado: (1982)

The Efficacy and Safety of Apatinib Treatment for Patients with Unresectable or Relapsed Liver Cancer: a retrospective study
por: Zhen, Liu, et al.
Publicado: (2018)

AdvanTIG-105: a phase I dose escalation study of the anti-TIGIT monoclonal antibody ociperlimab in combination with tislelizumab in patients with advanced solid tumors
por: Frentzas, Sophia, et al.
Publicado: (2023)

Novel Nutrition-Based Nomograms to Assess the Outcomes of Lung Cancer Patients Treated With Anlotinib or Apatinib
por: Zheng, Hui, et al.
Publicado: (2021)

A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors
por: Becerra, Carlos R., et al.
Publicado: (2014)

Phase 1 dose escalation study of seribantumab (MM-121), an anti-HER3 monoclonal antibody, in patients with advanced solid tumors
por: Denlinger, Crystal S., et al.
Publicado: (2021)

Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia. Recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series
por: Nunez-Roldan, A, et al.
Publicado: (1982)

Integrated Analysis Identifies DPP7 as a Prognostic Biomarker in Colorectal Cancer
por: Zhang, Wei, et al.
Publicado: (2023)

Phase I Dose‐Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors
por: Cao, Junning, et al.
Publicado: (2017)

A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer
por: Park, Soo Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_483h6tp73edc3cbkpmpv1oi6vb